In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter?

1. [No authors listed]

1996

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Lancet

348

1329

1339

2. FurukawaTAStreinerDLHoriS

2000

Discrepancies among megatrials.

J Clin Epidemiol

53

1193

1199

3. MontoriVMPermanyer-MiraldaGFerreira-GonzalezIBusseJWPacheco-HuergoV

2005

Validity of composite end points in clinical trials.

BMJ

330

594

596

4. ClarkeMChalmersI

1998

Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents.

JAMA

280

280

282

5. HalpernSDKarlawishJHBerlinJA

2002

The continuing unethical conduct of underpowered clinical trials.

JAMA

288

358

362

6. AltmanDGBlandJM

1995

Absence of evidence is not evidence of absence.

BMJ

311

485

7. MooreRAGavaghanDTramèrMRCollinsSLMcQuayHJ

1998

Size is everything—large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects.

Pain

78

217

220

8. DickersinKMinYI

1993

NIH clinical trials and publication bias.

Online J Curr Clin Trials

Doc No. 50

9. AltmanDG

1980

Statistics and ethics in medical research, III: how large a sample.

BMJ

281

1336

1338

10. MuellerPSMontoriVMBasslerDKoenigBAGuyattGH

2007

Ethical issues in stopping randomized trials early because of apparent benefit.

Ann Intern Med

146

878

881

11. MontoriVMDevereauxPJAdhikariNKBurnsKEEggertCH

2005

Randomized trials stopped early for benefit: a systematic review.

JAMA

294

2203

2209

12. SnowdonCElbourneDRGarciaJCampbellMKEntwistleVA

2006

Financial considerations in the conduct of multi-centre randomised controlled trials: evidence from a qualitative study.

Trials

7

34